DexCom is trading 15.86% down at $76.40 after an unexplained after-hours decline following its $90.80 regular-session close on August 12, 2026.
- No reliable company-specific announcement, earnings release, regulatory action, or analyst change was identified for the session.
- DexCom published an updated CONNECT study on August 12, but available coverage does not link it to the decline; the broader market was modestly positive.